We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TITN icon
14276
Titan Machinery
TITN
$431M
$523 ﹤0.01%
37
-34,923
-100% -$506K
SERA icon
14277
Sera Prognostics
SERA
$79.1M
$521 ﹤0.01%
+64
New +$470
CDXS icon
14278
PUT
Codexis
CDXS
$175M
$477 ﹤0.01%
100
XBPEW
14279
XBP Europe Holdings Warrant
XBPEW
$475 ﹤0.01%
11,866
-403
-3% -$14
BCAB icon
14280
CALL
BioAtla
BCAB
$5.73M
$473 ﹤0.01%
16
+6
+60% +$504
LONA
14281
PUT
LeonaBio Inc
LONA
$73.9M
$469 ﹤0.01%
80
-6,720
-99% -$37.9K
FRGE
14282
PUT
DELISTED
Forge Global Holdings
FRGE
$465 ﹤0.01%
+33
New +$544
SLXNW
14283
Silexion Therapeutics Warrant
SLXNW
$74.3K
$456 ﹤0.01%
13,580
-4,825
-26% -$194
DFSCW
14284
DEFSEC Technologies Warrant
DFSCW
$127K
$455 ﹤0.01%
22,098
+180
+0.8% +$4
SST icon
14285
PUT
System1
SST
$19.8M
$449 ﹤0.01%
50
+40
+400% +$403
PEPG icon
14286
PepGen
PEPG
$206M
$443 ﹤0.01%
+117
New +$729
TRVG
14287
PUT
trivago
TRVG
$367M
$436 ﹤0.01%
200
-300
-60% -$579
PAVMZ
14288
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$425 ﹤0.01%
42,892
+200
+0.5% +$4
BRLT icon
14289
CALL
Brilliant Earth
BRLT
$22.1M
$420 ﹤0.01%
200
-15,200
-99% -$27.9K
FTIIW
14290
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$418 ﹤0.01%
20,675
-321
-2% -$7
TACT icon
14291
CALL
Transact Technologies
TACT
$54.6M
$409 ﹤0.01%
100
SUP
14292
CALL
DELISTED
Superior Industries International
SUP
$408 ﹤0.01%
200
-100
-33% -$252
SOL
14293
PUT
DELISTED
Emeren Group
SOL
$406 ﹤0.01%
+200
New +$442
LANV.WS
14294
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$402 ﹤0.01%
+10,044
New +$253
RILY icon
14295
BRC Group Holdings
RILY
$304M
$399 ﹤0.01%
87
TRX icon
14296
PUT
TRX Gold Corp
TRX
$341M
$399 ﹤0.01%
1,300
-4,100
-76% -$1.5K
SYRS
14297
PUT
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$391 ﹤0.01%
1,700
-35,200
-95% -$42.3K
ATNM icon
14298
Actinium Pharmaceuticals
ATNM
$30.2M
$375 ﹤0.01%
298
+275
+1,196% +$427
SNAXW
14299
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$363 ﹤0.01%
47,733
+1,820
+4% +$10
MMLP icon
14300
CALL
Martin Midstream Partners
MMLP
$93.9M
$359 ﹤0.01%
100
-500
-83% -$1.98K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.